[1]
K. G.A and R. N.R., “THE USE OF EMPAGLYFLOSINE IN PATIENTS WITH CHRONIC CARDIAC FAILURE AND DYSFUNCTION OF THE KIDNEYS”, JMGCB, vol. 2, no. 12, pp. 602–606, Oct. 2025.